News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation

Please refer to our letter dated November 8 2022 wherein we have intimated the schedule of Investors/ Analysts call on November 14 2022. In this connection we enclose herewith the presentation that would be used in the Investors / Analysts call on the Un-audited Financial Results of the Company for the Second quarter and half year ended September 30 2022.The presentation is also being uploaded in the following weblink of the Company.https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/presentations/

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.